PD Dr. ID: 6360691

Marianne Sinn

graph of relations
Affiliations

Publications

  1. 2017
  2. Hepatotoxicity following systemic therapy for colorectal liver metastases and the impact of chemotherapy-associated liver injury on outcomes after curative liver resection

    Duwe, G., Knitter, S., Pesthy, S., Beierle, A. S., Bahra, M., Schmelzle, M., Schmuck, R. B., Lohneis, P., Raschzok, N., Öllinger, R., Sinn, M., Struecker, B., Sauer, I. M., Pratschke, J. & Andreou, A., 09.2017, In: EJSO-EUR J SURG ONC. 43, 9, p. 1668-1681 14 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  3. Incidence and Oncological Implications of Previously Undetected Tumor Multicentricity Following Pancreaticoduodenectomy for Pancreatic Adenocarcinoma in Patients Undergoing Salvage Pancreatectomy

    Andreou, A., Klein, F., Schmuck, R. B., Lee, D., Sinn, M., Denecke, T., Pratschke, J. & Bahra, M., 09.2017, In: ANTICANCER RES. 37, 9, p. 5269-5275 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Dose-escalated radiotherapy for unresectable or locally recurrent pancreatic cancer: Dose volume analysis, toxicity and outcome of 28 consecutive patients

    Zschaeck, S., Blümke, B., Wust, P., Kaul, D., Bahra, M., Riess, H., Klein, F., Sinn, M., Pelzer, U., Budach, V. & Ghadjar, P., 2017, In: PLOS ONE. 12, 10, p. e0186341

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. 2016
  6. Resting heart rate is an independent predictor of death in patients with colorectal, pancreatic, and non-small cell lung cancer: results of a prospective cardiovascular long-term study

    Anker, M. S., Ebner, N., Hildebrandt, B., Springer, J., Sinn, M., Riess, H., Anker, S. D., Landmesser, U., Haverkamp, W. & von Haehling, S., 12.2016, In: EUR J HEART FAIL. 18, 12, p. 1524-1534 11 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Einsatz von Neuen oralen Antikoagulanzien (NOAK) bei onkologischen Patienten

    Trappe, R. U., Sinn, M. & Riess, H., 09.2016, In: DEUT MED WOCHENSCHR. 141, 20, p. 1446-1450 5 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  8. P53 overexpression and Ki67-index are associated with outcome in ductal pancreatic adenocarcinoma with adjuvant gemcitabine treatment

    Striefler, J. K., Sinn, M., Pelzer, U., Jühling, A., Wislocka, L., Bahra, M., Sinn, B. V., Denkert, C., Dörken, B., Oettle, H., Riess, H., Bläker, H. & Lohneis, P., 08.2016, In: PATHOL RES PRACT. 212, 8, p. 726-34 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Second-Line Treatment in Pancreatic Cancer Patients: Who Profits?--Results From the CONKO Study Group

    Sinn, M., Dälken, L., Striefler, J. K., Bischoff, S., Schweitzer, N., Pelzer, U., Dörken, B., Riess, H. & Stieler, J. M., 04.2016, In: PANCREAS. 45, 4, p. 601-5 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. Perioperative treatment options in resectable pancreatic cancer - how to improve long-term survival

    Sinn, M., Bahra, M., Denecke, T., Travis, S., Pelzer, U. & Riess, H., 15.03.2016, In: WORLD J GASTRO ONCOL. 8, 3, p. 248-57 10 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  11. Primary prevention and treatment of venous thromboembolic events in patients with gastrointestinal cancers - Review

    Riess, H., Habbel, P., Jühling, A., Sinn, M. & Pelzer, U., 15.03.2016, In: WORLD J GASTRO ONCOL. 8, 3, p. 258-70 13 p.

    Research output: SCORING: Contribution to journalSCORING: Review articleResearch

  12. 2015
  13. Cytoreductive Surgery for Pancreatic Cancer Improves Overall Outcome of Gemcitabine-Based Chemotherapy

    Bahra, M., Pratschke, J., Klein, F., Neuhaus, P., Boas-Knoop, S., Puhl, G., Denecke, T., Pullankavumkal, J. R., Sinn, M., Riess, H. & Pelzer, U., 08.2015, In: PANCREAS. 44, 6, p. 930-6 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Human equilibrative nucleoside transporter 1 expression analysed by the clone SP 120 rabbit antibody is not predictive in patients with pancreatic cancer treated with adjuvant gemcitabine - Results from the CONKO-001 trial

    Sinn, M., Riess, H., Sinn, B. V., Stieler, J. M., Pelzer, U., Striefler, J. K., Oettle, H., Bahra, M., Denkert, C., Bläker, H. & Lohneis, P., 08.2015, In: EUR J CANCER. 51, 12, p. 1546-54 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Prognostic significance of DNA cytometry for adjuvant therapy response in pancreatic cancer

    Klein, F., Bahra, M., Schirmeier, A., Al-Abadi, H., Pratschke, J., Pelzer, U., Oettle, H., Striefler, J., Riess, H. & Sinn, M., 07.2015, In: J SURG ONCOL. 112, 1, p. 66-71 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Efficacy of Prophylactic Low-Molecular Weight Heparin for Ambulatory Patients With Advanced Pancreatic Cancer: Outcomes From the CONKO-004 Trial

    Pelzer, U., Opitz, B., Deutschinoff, G., Stauch, M., Reitzig, P. C., Hahnfeld, S., Müller, L., Grunewald, M., Stieler, J. M., Sinn, M., Denecke, T., Bischoff, S., Oettle, H., Dörken, B. & Riess, H., 20.06.2015, In: J CLIN ONCOL. 33, 18, p. 2028-34 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. 2014
  18. α-Smooth muscle actin expression and desmoplastic stromal reaction in pancreatic cancer: results from the CONKO-001 study

    Sinn, M., Denkert, C., Striefler, J. K., Pelzer, U., Stieler, J. M., Bahra, M., Lohneis, P., Dörken, B., Oettle, H., Riess, H. & Sinn, B. V., 11.11.2014, In: BRIT J CANCER. 111, 10, p. 1917-23 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. Second-line oxaliplatin, folinic acid, and fluorouracil versus folinic acid and fluorouracil alone for gemcitabine-refractory pancreatic cancer: outcomes from the CONKO-003 trial: outcomes from the CONKO-003 trial

    Oettle, H., Riess, H., Stieler, J. M., Heil, G., Schwaner, I., Seraphin, J., Görner, M., Mölle, M., Greten, T. F., Lakner, V., Bischoff, S., Sinn, M., Dörken, B. & Pelzer, U., 10.08.2014, In: J CLIN ONCOL. 32, 23, p. 2423-9 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. KRAS mutations in codon 12 or 13 are associated with worse prognosis in pancreatic ductal adenocarcinoma

    Sinn, B. V., Striefler, J. K., Rudl, M. A., Lehmann, A., Bahra, M., Denkert, C., Sinn, M., Stieler, J., Klauschen, F., Budczies, J., Weichert, W., Stenzinger, A., Kamphues, C., Dietel, M. & Riess, H., 05.2014, In: PANCREAS. 43, 4, p. 578-83 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Intensified chemotherapy and simultaneous treatment with heparin in outpatients with pancreatic cancer - the CONKO 004 pilot trial

    Pelzer, U., Hilbig, A., Stieler, J. M., Bahra, M., Sinn, M., Gebauer, B., Dörken, B. & Riess, H., 19.03.2014, In: BMC CANCER. 14, p. 204

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Multimodale Therapie des Pankreaskarzinoms

    Pelzer, U., Sinn, M., Stieler, J. & Riess, H., 01.2014, In: INTERNIST. 55, 1, p. 31-6 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Intensity-modulated and image-guided radiotherapy in patients with locally advanced inoperable pancreatic cancer after preradiation chemotherapy

    Sinn, M., Ganeshan, R., Graf, R., Pelzer, U., Stieler, J. M., Striefler, J. K., Bahra, M., Wust, P. & Riess, H., 2014, In: SCI WORLD J. 2014, p. 452089

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. 2013
  25. Does long-term survival in patients with pancreatic cancer really exist? Results from the CONKO-001 study

    Sinn, M., Striefler, J. K., Sinn, B. V., Sallmon, D., Bischoff, S., Stieler, J. M., Pelzer, U., Bahra, M., Neuhaus, P., Dörken, B., Denkert, C., Riess, H. & Oettle, H., 11.2013, In: J SURG ONCOL. 108, 6, p. 398-402 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Adjuvant chemotherapy with gemcitabine and long-term outcomes among patients with resected pancreatic cancer: Results from the CONKO-001 study

    Oettle, H., Neuhaus, P., Hochhaus, A., Hartmann, J. T., Gellert, K., Ridwelski, K., Niedergethmann, M., Zülke, C., Fahlke, J., Arning, M. B., Sinn, M., Hinke, A. & Riess, H., 09.10.2013, In: JAMA-J AM MED ASSOC. 310, 14, p. 1473-81 9 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Primäre medikamentöse Thromboembolieprophylaxe bei ambulanten Patienten mit fortgeschrittenem Pankreaskarzinom unter Chemotherapie?

    Pelzer, U., Sinn, M., Stieler, J. & Riess, H., 10.2013, In: DEUT MED WOCHENSCHR. 138, 41, p. 2084-8 5 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Interventionally implanted port catheter systems for hepatic arterial infusion of chemotherapy in patients with primary liver cancer: a phase II-study (NCT00356161)

    Sinn, M., Nicolaou, A., Ricke, J., Podrabsky, P., Seehofer, D., Gebauer, B., Pech, M., Neuhaus, P., Dörken, B., Riess, H. & Hildebrandt, B., 09.08.2013, In: BMC GASTROENTEROL. 13, p. 125

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. Hepatic arterial infusion with oxaliplatin and 5-FU/folinic acid for advanced biliary tract cancer: a phase II study

    Sinn, M., Nicolaou, A., Gebauer, B., Podrabsky, P., Seehofer, D., Ricke, J., Dörken, B., Riess, H. & Hildebrandt, B., 08.2013, In: DIGEST DIS SCI. 58, 8, p. 2399-405 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  30. Blood group determinates incidence for pancreatic cancer in Germany

    Pelzer, U., Klein, F., Bahra, M., Sinn, M., Dörken, B., Neuhaus, P., Meyer, O. & Riess, H., 2013, In: FRONT PHYSIOL. 4, p. 118

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Value of carbohydrate antigen 19-9 in predicting response and therapy control in patients with metastatic pancreatic cancer undergoing first-line therapy

    Pelzer, U., Hilbig, A., Sinn, M., Stieler, J., Bahra, M., Dörken, B. & Riess, H., 2013, In: FRONT ONCOL. 3, p. 155

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. 2012
  33. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma

    Schnapauff, D., Denecke, T., Grieser, C., Collettini, F., Colletini, F., Seehofer, D., Sinn, M., Banzer, J., Lopez-Hänninen, E., Hamm, B., Wust, P. & Gebauer, B., 06.2012, In: CARDIOVASC INTER RAD. 35, 3, p. 581-7 7 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Biliary tract cancer: a survey regarding the current oncological daily care practice in Germany

    Sinn, M., Bischoff, S., Nehls, O., Pelzer, U., von Weizsäcker, F., Kubicka, S., Stieler, J. M., Caca, K. & Riess, H., 2012, In: ONKOLOGIE. 35, 12, p. 755-60 6 p.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Previous 1 2 Next